Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Carrier‐Free, Amorphous Verteporfin Nanodrug for Enhanced Photodynamic Cancer Therapy and Brain Drug Delivery

Advanced Science(2024)10.1002/advs.202302872Source: DataRank Database

Carrier‐Free, Amorphous Verteporfin Nanodrug for Enhanced Photodynamic Cancer Therapy and Brain Drug Delivery is a research paper published in Advanced Science (2024). On theSindex it has a DataRank of 0. It has been cited 32 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access32 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 3.99)OA: goldTopics (74)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Collin T. Inglut ORCID,Payal Srivastava ORCID,Idrisa Rahman,Jillian Stabile,Brandon Gaitan

Live enrichment

PubMed:38445882 PMC:PMC11077681 OpenAlex:https://openalex.org/W4392506820

National Institutes of Health

Grant: R21EB028508

National Science Foundation

Grant: 2030253

Photosensitizing Nanoconstructs for Regulation of ATP-Binding Cassette Transporters in the Brain

National Institutes of Health

Grant: 5R21EB028508-02

Photodynamic Priming for Bidirectional Modulation of Drug Transport Across the Blood-Brain Tumor Barrier

FWCI

3.99

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/advs.202302872

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/advs.202302872

publisherhttps://advanced.onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202302872

journalhttps://doi.org/10.1002/advs.202302872

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38445882

Fields of Study

Nanoplatforms for cancer theranosticsPhotodynamic Therapy Research StudiesGlioma Diagnosis and Treatment0301 basic medicine03 medical and health sciences0302 clinical medicineAnimalsPhotochemotherapyVerteporfinMicePhotosensitizing AgentsBrain NeoplasmsDrug Delivery SystemsGlioblastomaNanoparticlesDisease Models, AnimalHumansRatsLiposomesCell Line, TumorBrain

MeSH Terms

VerteporfinAnimalsBrainBrain NeoplasmsDisease Models, AnimalGlioblastomaHumansLiposomesPhotochemotherapyDrug Delivery SystemsPhotosensitizing AgentsCell Line, TumorMiceRatsNanoparticles

Keywords

PhotosensitizerVerteporfinPhotodynamic therapyLiposomeCancer researchDrugDrug deliveryPharmacologyBlood–brain barrierChemistryMedicineBiophysicsBiologyBiochemistryInternal medicinePhotochemistryCentral nervous systemCancerPhotosensitizersBlood‐brain BarrierAmorphous Drug NanoparticlesScienceMiceDrug Delivery SystemsCell Line, TumorAnimalsHumansResearch ArticlesPhotosensitizing AgentsBrain NeoplasmsQBrainRatsDisease Models, AnimalPhotochemotherapyLiposomesNanoparticlesGlioblastoma

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being